Booya Fargol, Akram Salma, Fletcher Joel G, Huprich J E, Johnson C D, Fidler J L, Barlow J M, Solem C A, Sandborn W J, Loftus Edward V
Department of Radiology, Mayo Clinic Rochester, Rochester, MN 55905, USA.
Abdom Imaging. 2009 Jul;34(4):467-75. doi: 10.1007/s00261-008-9419-1.
To estimate the clinical benefit of CT enterography (CTE) in patients with fistulizing Crohn's disease and describe the appearance of fistulas at CTE.
Crohn's patients who had undergone CTE, which diagnosed an abscess or fistula, were identified. A gastroenterologist reviewed clinical notes prior to and following CTE to assess the pre-CTE clinical suspicion for fistula/abscess, and post-CTE alteration in patient management. A radiologist reassessed all fistula-positive cases, which were confirmed by a non-CT reference standard, to describe their radiologic appearance.
Fifty-six patients had CT exams identifying 19 abscesses and 56 fistulas. There was no or remote suspicion of fistula or abscess at pre-imaging clinical assessment in 50% of patients. Thirty-four patients (61%) required a change in or initiation of medical therapy and another 10 (18%) underwent an interventional procedure based on CT enterography findings. Among 37 fistulas with reference standard confirmation, 30 (81%) were extraenteric tracts, and 32 (86%) were hyperenhancing compared to adjacent bowel loops. Most fistulas (68%) contained no internal air or fluid.
CTE detects clinically occult fistulas and abscesses, resulting in changes in medical management and radiologic or surgical intervention. Most fistulas appear as hyperenhancing, extraenteric tracts, usually without internal air or fluid.
评估CT小肠造影(CTE)对瘘管性克罗恩病患者的临床益处,并描述CTE检查时瘘管的表现。
纳入接受CTE检查且诊断出脓肿或瘘管的克罗恩病患者。一名胃肠病学家查阅CTE检查前后的临床记录,以评估CTE检查前对瘘管/脓肿的临床怀疑情况以及CTE检查后患者治疗管理的变化。一名放射科医生重新评估所有经非CT参考标准证实的瘘管阳性病例,以描述其影像学表现。
56例患者接受了CT检查,发现19个脓肿和56个瘘管。50%的患者在影像学检查前的临床评估中未发现或仅有远距离的瘘管或脓肿怀疑。34例患者(61%)需要改变或开始药物治疗,另外10例患者(18%)根据CT小肠造影结果接受了介入治疗。在37个经参考标准证实的瘘管中,30个(81%)为肠外通道,与相邻肠袢相比,32个(86%)表现为强化增强。大多数瘘管(68%)内无气体或液体。
CTE可检测出临床隐匿性瘘管和脓肿,从而导致药物治疗管理以及放射学或外科干预的改变。大多数瘘管表现为强化增强的肠外通道,通常无气体或液体。